Form: 20-F

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

March 26, 2026

Exhibit 15.1

 

Kost Forer Gabbay & Kasierer
144 Menachem Begin Road, Building A
Tel-Aviv 6492102, Israel
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the following Registration Statements:

 

(1)Registration Statements (Form F-3 Nos. 333-238731, 333-269087 and 333-292640) of CollPlant Biotechnologies Ltd., and

 

(2) Registration Statements (Form S-8 Nos. 333-229163, 333-248479, 333-263842 and 333-271320) pertaining to the Share Ownership and Option Plan (2010) of CollPlant Biotechnologies Ltd., and
   
(3) Registration Statement (Form S-8 No. 333-279791) pertaining to the 2024 Share Award Plan of CollPlant Biotechnologies Ltd.

 

of our report dated March 26, 2026, with respect to the consolidated financial statements of CollPlant Biotechnologies Ltd. included in this Annual Report (Form 20-F) of CollPlant Biotechnologies Ltd. for the year ended December 31, 2025.

 

/s/ Kost Forer Gabbay & Kasierer  
A Member of EY Global  
   
Tel Aviv, Israel  
March 26, 2026